Patents by Inventor Joris Vriens

Joris Vriens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocycle derivatives for treating TRPM3 mediated disorders
    Patent number: 12209081
    Abstract: The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain and inflammatory hypersensitivity. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.
    Type: Grant
    Filed: May 12, 2024
    Date of Patent: January 28, 2025
    Assignee: Katholieke Universiteit Leuven
    Inventors: Patrick Chaltin, Arnaud Marchand, Jean-Christophe Vanherck, Thomas Voets, Joris Vriens, Melanie Reich, André Welbers
  • Treatment of pain
    Patent number: 9194863
    Abstract: The present invention relates to the use of an antagonist of the non-selective cation channel TRPM3 as a medicine for the treatment of pain. The present invention further relates to a method for identification of novel compounds for the treatment of pain, such as TRPM3-antagonists and compounds that modulate the activity or expression of TRPM3. The present invention relates to the use of TRPM3 antagonists as analgesics and the use of the compounds of this invention for the treatment of pain such as but not limited to inflammatory hyperalgesia.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: November 24, 2015
    Assignee: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Thomas Voets, Joris Vriens
  • NOVEL TREATMENT OF PAIN
    Publication number: 20140079640
    Abstract: The present invention relates to the use of an antagonist of the non-selective cation channel TRPM3 as a medicine for the treatment of pain. The present invention further relates to a method for identification of novel compounds for the treatment of pain, such as TRPM3-antagonists and compounds that modulate the activity or expression of TRPM3. The present invention relates to the use of TRPM3 antagonists as analgesics and the use of the compounds of this invention for the treatment of pain such as but not limited to inflammatory hyperalgesia.
    Type: Application
    Filed: May 4, 2012
    Publication date: March 20, 2014
    Applicant: KATHOLIEKE UNIVERSITEIT LEUVEN
    Inventors: Thomas Voets, Joris Vriens